Back to results
Completed

Intranasal Esketamine to Maintain the Antidepressant Response to IV Racemic Ketamine

NCT04856124

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

PsychAtlanta

Marietta, Georgia, United States

View on ClinicalTrials.gov
Intranasal Esketamine to Maintain the Antidepressant Response to IV Racemic Ketamine — TrialFind